SCHEMBL23440117

SCHEMBL23440117

O=C(NCc1ccco1)c1ccccc1NSc1ccc2c(c1)CCC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 11/20 0.51
▸ MAPT P10636 4/20 0.51
▸ POLB P06746 3/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ HTT P42858 2/20 0.48
▸ KDM4E B2RXH2 7/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ALDH1A1 P00352 8/20 0.47
▸ NPSR1 Q6W5P4 3/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ HSD17B10 Q99714 5/20 0.46
▸ TSHR P16473 3/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23439800 0.98 HPGD (0.51) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23440348 0.84 HPGD (0.60) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23440431 0.83 NPSR1 (0.60) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23440346 0.82 HPGD (0.56) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23439713 0.81 HPGD (0.60) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23440433 0.81 TDP1 (0.58) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23440341 0.81 SMN1; SMN2 (0.61) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23439540 0.79 ALDH1A1 (0.70) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23413013 0.77 ALDH1A1 (0.70) HPGDMAPTPOLBSMN1; SMN2HTT
SCHEMBL23440151 0.74 HPGD (0.55) HPGDMAPTPOLBSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105906-A1 ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE GAIN THERAPEUTICS SA (CH) 2021-06-03 — — WO disclosed
Send feedback